Clarity Pharmaceuticals

Australia
Sydney, New South Wales, Australia, 2015

Company profile

Clarity Pharmaceuticals company profile

Clarity is a personalized medicine company focused on the treatment of serious disease. The Company is a leader in innovative radiopharmaceutical technology, developing targeted therapies and assisting in the drug development pipeline of novel therapies for companies globally. Clarity’s platform technology allows antibodies to be radiolabeled and visualized using PET imaging. The human imaging data generated provides information on whether the drug reaches the desired disease target in a patient. This information enables a personalized approach to therapy by only treating those patients that are likely to respond to therapy and excluding those that won’t respond to therapy. This precision medicine approach is at the forefront of drug development.

Business identity

Contact email
[email protected]
Phone number
+610292094037
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2010-01-01, Year

Headquarters

Postal code
2015
Country code
AU
Continent
Oceania

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$138.6M
Last funding
Post IPO Equity / $132.4M / 2025-07-28
Last equity funding
Post IPO Equity / $132.4M
Investors
5
Lead investors
2
Founders
1
Articles
85
Exited on
2021-08-25

Founders and investors

Founders

Matt Harris

Lead investors

Australian Nuclear Science and Technology OrganizationSydney Angels

Investors

ATP InnovationsAustralian Nuclear Science and Technology OrganizationCicada InnovationsSydney AngelsUniversity of Melbourne